[In the Media] Antimicrobial Resistance (AMR) Awareness Month – The Issue of Antimicrobial Resistance, The Promotion of Drug Discovery and Stable Supply (Medical Tribune, November 10, 2022)
date : 12/5/2022
Tags: AMR
![[In the Media] Antimicrobial Resistance (AMR) Awareness Month – The Issue of Antimicrobial Resistance, The Promotion of Drug Discovery and Stable Supply (Medical Tribune, November 10, 2022)](https://hgpi.xsrv.jp/en/wp-content/uploads/sites/2/AMRalliance-logo-11-27.jpg){kind=logo}
Health and Global Policy Institute (HGPI) has been tackling the issue of Antimicrobial Resistance (AMR) since 2016 and serves as the secretariat of AMR Alliance Japan.
On November 10, 2022, the Medical Tribune featured a media forum held on November 8 by the International Committee of the Japan Pharmaceutical Manufacturers Association (JPMA) in cooperation with the AMR Alliance Japan, entitled “Toward Antimicrobial Resistance (AMR) Awareness Month.”
For more details, please refer here.
*Available only in Japanese
**The full article can be read after logging in.
Top Research & Recommendations Posts
- [Research Report] The Public Opinion Survey on Mental Health (August 12, 2022)
- [Recommendations] Creating a Long-Term Care System for the Era of Healthy Longevity –Five Discussion Points Revealed by Current Circumstances and Three Perspectives For The Future (March 31, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [Research Paper] “Association of Women’s Health Literacy and Work Productivity among Japanese Workers” Published in JMA Journal (July 15, 2020)
- [Research Report] Public Opinion Survey on Priorities for Policies Related to Children’s Health (January 17, 2022)
